Trials / Recruiting
RecruitingNCT04576130
A Danish ICD-study in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation
A Danish Study to Assess the Efficacy of Implantable Cardioverter Defibrillator in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation Who Receive Complete Revascularization
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,200 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
DanICD is a randomized, controlled study to with the aim to assess whether there is a benefit of ICD-implantation in patients with coronary artery disease (including acute myocardial infarction), who survive cardiac arrest due to ventricular fibrillation/sustained ventricular tachycardia and undergo revascularization and with an LVEF above 35%.
Conditions
- Coronary Artery Disease
- Acute Myocardial Infarction
- Ventricular Fibrillation
- Ventricular Tachycardia, Sustained
- Out-Of-Hospital Cardiac Arrest
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantable cardioverter defibrillator | Implantation of an ICD for secondary prevention |
Timeline
- Start date
- 2020-10-12
- Primary completion
- 2032-10-01
- Completion
- 2032-10-01
- First posted
- 2020-10-06
- Last updated
- 2025-01-27
Locations
1 site across 1 country: Denmark
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04576130. Inclusion in this directory is not an endorsement.